Market Roundup: Down Week on Global and Biotechnology Data

Economy/Stock Market

The week began just slightly up after last Friday’s red session. While the broader market experienced gains, the overall results were tempered with a tumble in Biotechnology stocks following criticism from Hilary Clinton and the New York Times. Global stocks fell the next day, dragged down by shares of miners and other raw materials producers. Biotechnology drug makers suffered another day of criticism, resulting in their stock prices declining. Stock prices in Europe fell on news that Volkswagen’s clean diesel engines produce more emissions than U.S. and European standards allow. U.S. stock markets continued to lag mid-week with crude oil falling to $44.48 a barrel. Down trading sessions on Thursday and Friday cumulated the week’s red results. Labor Department data showed new jobless claims climbed by 3,000 to 267,000.